Form 4: Procter & Gamble CFO Andre Schulten Reports Stock Option Grant and Share Sale

Andre Schulten, CFO of Procter & Gamble, reports the acquisition of stock options and the sale of common stock to cover tax obligations.

Summary

• On October 1, 2024, Andre Schulten, Chief Financial Officer of Procter & Gamble, was granted stock options for 85,762 shares.
• On October 2, 2024, Schulten sold 1,569 shares of common stock at a price of $171.6541 per share.
• The sale was to cover tax obligations upon the settlement of a Restricted Stock Unit Award.
• Following the reported transactions, Schulten directly owns 35,639.2045 shares of common stock and indirectly owns 6,182.514 shares through a retirement plan trustee.
• Schulten also holds options to buy 85,762 shares of common stock, exercisable from October 1, 2027, to September 29, 2034.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations, without indicating any significant strategic shifts or concerns.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in company stock. This filing indicates routine activity related to stock-based compensation and tax obligations.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for corporate insiders in publicly traded companies, ensuring transparency in their trading activities.
• Similar filings are common among executives at comparable companies like Unilever (UL), Nestle (NSRGY), and Johnson & Johnson (JNJ), reflecting stock option grants and sales for tax purposes.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders as they are related to executive compensation and tax obligations.
• The filing provides transparency to shareholders regarding insider transactions.

Key Dates